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ABSTRACT
A fundamental property of neural crest (NC) migration is contact
inhibition of locomotion (CIL), a process by which cells change their
direction of migration upon cell contact. CIL has been proven to
be essential for NC migration in amphibians and zebrafish by
controlling cell polarity in a cell contact-dependent manner. Cell
contact during CIL requires the participation of the cell adhesion
molecule N-cadherin, which starts to be expressed by NC cells as a
consequence of the switch between E- and N-cadherins during
epithelial-to-mesenchymal transition (EMT). However, the mechanism
that controls the upregulation of N-cadherin remains unknown. Here,
we show that platelet-derived growth factor receptor alpha (PDGFRα)
and its ligand platelet-derived growth factor A (PDGF-A) are
co-expressed in migrating cranial NC. Inhibition of PDGF-A/PDGFRα
blocks NC migration by inhibiting N-cadherin and, consequently,
impairing CIL. Moreover, we identify phosphatidylinositol-3-kinase
(PI3K)/AKT as a downstream effector of the PDGFRα cellular
response during CIL. Our results lead us to propose PDGF-A/
PDGFRα signalling as a tissue-autonomous regulator of CIL by
controlling N-cadherin upregulation during EMT. Finally, we show that
once NC cells have undergone EMT, the same PDGF-A/PDGFRα
works as an NC chemoattractant, guiding their directional migration.
KEY WORDS: PDGF, PDGFR, Neural Crest, EMT, Contact inhibition
of locomotion, N-cadherin, Migration, Xenopus
INTRODUCTION
One of the most migratory cell types during early vertebrate
development is cells of the neural crest (NC). The NC has a transient
cell population, induced between the neural tube and surface
ectoderm, which eventually gives rise to many different tissues,
such as craniofacial cartilage and bone, cells of the peripheral
nervous system, smooth muscle cells, tendons and pigment cells.
Disruption of NC cell migration during development can lead
to pathologies including craniofacial abnormalities, heart
malformation and colonic aganglionosis (Hirschprung’s disease),
generally termed neurocristopathies (Feiner et al., 2001; Miyagawa-
Tomita et al., 1991; Van de Putte et al., 2007).
A defining characteristic of NC cells is the epithelial-to-
mesenchymal transition (EMT) they undergo to segregate from the
neural tube and start their migration (Theveneau and Mayor, 2012).
EMT is a cellular process that converts nonmotile epithelial cells to
motile mesenchymal cells, defined by a change in cell-cell adhesion,
polarity and the acquisition of migratory properties (Thiery et al.,
2009). One of the migratory properties acquired during NC cell EMT
is contact inhibition of locomotion (CIL) (Scarpa et al., 2015). This
cellular process is characterized by a change in direction of migration
upon cell-cell contact and is associated with embryonic processes,
such as neuronal cell and macrophage dispersion, and collective
migration of cranial NC cells (Carmona-Fontaine et al., 2008b; Davis
et al., 2012; Kay et al., 2012; Stramer and Mayor, 2016). EMT in
Xenopus and zebrafish cranial NC is defined by an acquisition of CIL,
which has been linked to a switch from E- to N-cadherin (also known
as cadherins 1 and 2, respectively) (Scarpa et al., 2015). This N-
cadherin upregulation has been shown to be essential for CIL-
dependent polarity in NC collective migration (Mayor and Etienne-
Manneville, 2016; Theveneau et al., 2010, 2013). However, the
mechanism of N-cadherin upregulation during NCmigration remains
unknown. The platelet-derived growth factor (PDGF) receptor
tyrosine kinase pathway has been implicated in EMT during cancer
invasion (Eckert et al., 2011; Jechlinger et al., 2006; Thiery and
Sleeman, 2006), and it is essential for the correct development of
several NC derivatives (Morrison-Graham et al., 1992; Soriano, 1997;
Tallquist and Soriano, 2003). Furthermore, evidence suggests that the
involvement of the PDGF pathway in the formation of NC derivatives
is related to the control of NC cell migration and proliferation
(Eberhart et al., 2008; He and Soriano, 2013; Smith and Tallquist,
2010). However, the specific mechanism bywhich PDGF controls the
formation of NC-derived tissues has not been completely elucidated.
The PDGF signalling pathway is activated by five soluble,
disulphide-linked, homo- or heteromeric ligands (PDGF-AA,
PDGF-AB, PDGF-BB, PDGF-CC, PDGF-DD) that bind to three
receptor tyrosine kinases (PDGFRα/Rα, PDGFRβ/Rβ, PDGFRα/
Rβ), leading to the subsequent activation of downstream signalling
cascades (Hoch and Soriano, 2003). These can affect a wide range
of cellular events, such as proliferation, migration, survival and
EMT. Functional in vivo interaction studies in mice demonstrated
that platelet-derived growth factor A (PDGF-A) and PDGF-C
activate platelet-derived growth factor receptor alpha (PDGFRα)
signalling (Boström et al., 1996; Ding et al., 2004; Soriano, 1997).
PDGFRα is expressed in cranial NC cells in Xenopus, zebrafish and
mouse embryos (Ho et al., 1994; Liu et al., 2002b; Orr-Urtreger
et al., 1992; Takakura et al., 1997; Fantauzzo and Soriano, 2016).
PDGFRα signalling, together with its ligand PDGF-A, has been
suggested to work as a chemotactic cue for NC cells (Eberhart et al.,
2008; He and Soriano, 2013; Kawakami et al., 2011). Perturbations
of PDGFRα signalling in mouse and zebrafish lead to severe defectsReceived 9 December 2016; Accepted 15 May 2017
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in cranial NC cell-derived tissues, suggesting a role for PDGFRα
signalling in the development of the NC towards its craniofacial
targets (Eberhart et al., 2008; He and Soriano, 2013; Morrison-
Graham et al., 1992; Soriano, 1997; Tallquist and Soriano, 2003).
By contrast, PDGFRβ signalling does not seem to be required for
NC cell development (Levéen et al., 1994; McCarthy et al., 2016;
Tallquist et al., 2000). However, a recent publication showed that
PDGFRα and PDGFRβ can form a functional heterodimer, and that
double knockdown mutants exhibit a more severe craniofacial
phenotype than those with either mutation alone (Fantauzzo and
Soriano, 2016). Analysis of the downstream signalling binding sites
of PDGFRα during mouse craniofacial development revealed the
phosphatidylinositol-3-kinase (PI3K)/AKT signalling pathway as
the primary signalling effector (Klinghoffer et al., 2001; McCarthy
et al., 2013; Vasudevan et al., 2015). However, very little is known
about early roles of PDGFRα signalling in cranial NC migration.
Here, we use Xenopus cranial NC cells to investigate the role of
PDGF signalling in NC migration. We show that PDGF-A and its
receptor PDGFRα are specifically co-expressed in pre-migratory and
migratory NC cells. We find that PDGF-A works as a chemotactic
signal for migratory, but not pre-migratory, NC cells. Analysis of this
pre-migratory phenotype shows that inhibition of PDGF-A/PDGFRα
blocks cell dispersion by downregulation of N-cadherin, which is
required for CIL acquisition during EMT. Furthermore, we find that
this novel role of PDGF signalling in the NC requires downstream
activity of the PI3K/AKT signalling pathway.
RESULTS
PDGF-A and PDGFRα are co-expressed in the NC and are
required for NC migration
We first analysed the expression of PDGFRα and PDGF-A by in
situ hybridization and RT-PCR. We found that PDGFRα is
expressed in pre-migratory (stage 18) and migrating (stage 24)
cranial NC cells, as shown by comparison with the specific NC
markers slug and twist (Fig. 1A-F). Expression of pdgf-awas found
in pre-migratory NC (Fig. 1G) and also in tissues surrounding the
migrating NC (Fig. 1H,I), as previously described (Ho et al., 1994).
To confirm this finding, we performed RT-PCR in NC dissected
from stage 18 embryos (pre-migratory), and observed strong
expression of pdgfa in the dissected tissue (Fig. 1J). To test for
non-NC tissue contamination, we also performed RT-PCR for a
neural plate marker (Sox2), an ectoderm marker (e-Keratin) and
a mesoderm marker (brachyury), and for an NC marker (Sox9) as a
positive control. We did not detect any of the non-NC tissue markers
in our NC samples, which were positive for the NCmarker (Fig. 1J).
The expression of PDGFRα in the NC was further confirmed by
immunostaining (Fig. 1K) and western blotting (Fig. 1L,M). These
data strongly support the notion that PDGF-A and PDGFRα are co-
expressed in the migrating NC.
In order to analyse the role of PDGF-A/PDGFRα in NCmigration,
we developed an anti-sense morpholino (PDGFRα MO), which
reduced PDGFRα protein levels with high efficiency (Fig. 1L,M). In
addition, we used previously published tools, such as a morpholino
against the receptor ligand (PDGF-A MO) (Nagel et al., 2004) and a
dominant-negative form of PDGFRα (PDGFRαw37 mRNA)
(Ataliotis et al., 1995). Depletion of PDGFRα, or its ligand PDGF-
A, led to the significant inhibition of NC cell migration in vivo
(Fig. 2A,B), without affecting NC specification (Fig. 2C,D),
suggesting that it affected a specific mechanism during migration
without any effect on NC cell induction. To verify the specificities of
the receptor and ligandmorpholinos, we co-injected themwithmouse
mRNA, which does not hybridize with the Xenopus laevis target
sequence in the morpholinos (see Materials and Methods), and
analysed the effect onNCmigration. For bothmorpholinos (PDGF-A
MO and PDGFRα MO), co-injection with their respective mRNAs
rescued NC migration back to wild-type levels (Fig. 2E-H).
Fig. 1. NC cells express both PDGF-A and
PDGFRα. (A-I) Whole-mount in situ
hybridization of Xenopus embryos.
(A,D,G) Lateral view of stage 18 embryos
showing expression of (A) slug, (D) pdgfrα and
(G) pdgf-a. (B,E,H) Lateral view of stage 24
embryos showing migrating NC expressing
(B) twist, (E), pdgfrα and (H) pdgf-a. Scale bar:
1 mm. Grey stars indicate the eyes.
(C,F,I) Sections of embryos shown in B,E,H,
respectively. The line in B indicates the level of
the section. Yellow dashed lines outline
cephalic NC streams. (J) RT-PCR analysis of
pdgf-a and pdgfrα expression in NC dissected
from stage 18 embryos (premig. NC) and whole
embryos along with Sox9 (NC marker), Sox2
(neural plate marker), brachyury (mesoderm
marker), e-Keratin (epidermis marker) and
ODC (control, ornithine decarboxylase).
(K) Immunostaining for PDGFRα (green),
Phalloidin (red) and DAPI (blue) in NC explants.
Scale bars: 20 µm. (L) Western blot analysis of
PDGFRα in NC dissected from control embryos,
embryos treated with PDGF-A or embryos
injected with PDGFRα MO. GADPH was used
as a loading control. (M) Band intensity
normalized to the loading control. Data are
mean±s.d. of three independent experiments.
AU, arbitrary units. ns, not significant;
***P<0.001.
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To investigate possible changes in NC cell motility resulting from
PDGF signalling depletion, NC cells were dissociated and single-
cell migration was monitored using time-lapse microscopy.
Analysis of cell motility did not reveal any difference in cell
velocity between PDGFRαMO-injected and control cells (Fig. 2I,J),
suggesting that inhibition of PDGFRα does not affect the motility of
single cells. Taken together, these data indicate that inhibition of
PDGF-A/PDGFRα signalling impairs NCmigration in vivo and that
this phenotype is not caused by an effect on cell motility per se.
Migratory but not pre-migratory NC cells chemotax towards
PDGF-A
Inhibition of migration by depletion of PDGF signalling could be
due to decreased chemotaxis, as PDGF-A has been suggested to
work as a chemoattractant for NC cells in zebrafish and mouse
(Eberhart et al., 2008; Kawakami et al., 2011). To test whether
impaired NC migration after PDGFRα inhibition is caused by
inhibition of chemotaxis towards PDGF-A, we used a previously
published in vitro chemotaxis bead assay (Theveneau and Mayor,
2011; Theveneau et al., 2010). Control and PDGFRα MO-injected
explants were plated in close proximity to PDGF-A protein-coated
beads, and their migratory behaviour was analysed by time-lapse
microscopy. Indeed, control explants showed strong chemotaxis
towards the PDGF-A source (Fig. 3A,B; Movie 1). Furthermore,
depletion of PDGFRα inhibited chemotaxis towards the PDGF-A
beads (Fig. 3A,B; Movie 1), indicating that PDGF-A might work as
a chemoattractant. To test whether the inhibition of chemotaxis in
PDGFRαMO-injected NC is caused by loss of transmission of the
chemotaxis signal and not by loss of migratory behaviour, we
investigated whether PDGFRα-depleted explants are still able to
migrate towards the knownNC chemoattractant stromal cell-derived
factor 1 (SDF-1) (Belmadani, 2005; Olesnicky Killian et al., 2009;
Theveneau et al., 2010). We observed no difference in migration
towards the SDF-1 source between the PDGFRα-depleted and
control NC explants (Fig. 3A,B; Movie 1), indicating that the effect
of PDGF-A/PDGFRα chemotaxis is independent of the role of
SDF-1 in NC cell migration. Taken together, these results suggest
that PDGF-Amight work as a chemoattractant in XenopusNC cells.
As PDGFRα is expressed at pre-migratory and migratory stages,
we performed a temporal analysis of the chemotaxis response. We
found that although migratory NC cells (stage 22) exhibited a strong
chemotaxis response (Fig. 3C, mig.), pre-migratory NC cells (stage
18) did not migrate towards PDGF-A (Fig. 3C, premig.; Movie 2).
To verify that this lack of chemotaxis in pre-migratory NC cells is
Fig. 2. PDGF-A and PDGFRα are required for NC migration in vivo. (A-D) PDGF signalling depletion affects NC migration, but not specification. (A) In situ
hybridization of twist in stage 24 embryos after the indicated treatments. Scale bars: 1 mm. (B) Diagram of quantification of NC migration; distance of the second
(hyoid) NC stream on the injected side was normalized to that on the uninjected control side. Bar graph of NC migration in control (n=30), dominant-negative
mRNA (dnmRNA) (PDGFRαw37, n=51), PDGF-AMO (n=47) and PDGFRαMO (n=28) embryos, from three independent experiments. (C) In situ hybridization of
slug in stage 18 embryos after the indicated treatments. Dorsal view, yellowarrows indicate the site of injection. Scale bar: 500 μm. (D) Analysis of NC induction as
shown in C. (E) In situ hybridization of twist in stage 24 embryos after the indicated treatments. Scale bar: 1 mm. (F) PDGF-A MO rescue experiment showing
specificity of MO treatment. NCmigration in control (n=30), PDGF-AMO (n=24), mouse PDGF-AmRNA (n=28), PDGF-AMO andmouse PDGF-AmRNA (n=27)
embryos. (G) In situ hybridization of twist in stage 24 embryos after the indicated treatments. Scale bar: 1 mm. Stars indicate the eye and red arrows indicate the
neural crest streams. (H) PDGRFαMO rescue, showing the specificity of theMO treatment. NCmigration in control (n=20), PDGFRαMO (n=36), mouse PDGFRα
mRNA (n=22), and PDGFRα MO+mouse PDGFRα mRNA (n=41) embryos. (I) Analysis of NC motility (µm/sec) in control (n=202) and PDGFRα MO-injected
(n=208) single cells from three independent experiments. Scatter plots showmedian and interquartile range. (J) Images showing representative tracks of nuclear
RFP-injected cells over 5 h. Scale bar: 50 µm. In all bar graphs, data are mean±s.e.m. ns, not significant; ***P<0.001.
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not due to a general inability of pre-migratory NC cells to react to a
chemotactic cue, we performed a pre-migratory chemotaxis assay
with SDF-1. No change in chemotaxis behaviour towards the
SDF-1 protein source in either pre-migratory or migratory NC
explants was observed (Fig. 3C,D;Movie 2). Taken together, these
data indicate that chemotaxis of NC towards PDGF-A is present
only in migrating NC cells, and its absence in pre-migratory cells
suggests a role of PDGF-A/PDGFRα at these early stages that does
not involve chemotaxis. As a role of PDGF on NC chemotaxis has
already been described (Eberhart et al., 2008; He and Soriano,
2013; Kawakami et al., 2011; Shellard and Mayor, 2016), we
decided to focus our investigation on the early nonchemotactic
role of PDGF.
PDGF-A/PDGFRα controls dispersion via N-cadherin
regulation
Initial migration of NC requires EMT; therefore, we tested the
possibility that impaired NCmigration could be caused by defects in
EMT. To assess the potential influence of PDGF signalling on EMT,
NC cell dispersion was analysed in the pre-migratory NC (stage 18).
Nuclear fluorescence-labelled NC cell clusters were monitored by
time-lapse microscopy, and cell dispersion was quantified by
measuring the distance between the nucleus of an NC cell and that
of its nearest neighbour using Delaunay triangulation (Carmona-
Fontaine et al., 2011). Inhibition of PDGF-A (Fig. 4C,G) and
PDGFRα (Fig. 4E,G) drastically reduced NC cell dispersion
compared with control explants (Fig. 4A,G), confirming our
previous observation that both PDGFRα and PDGF-A are co-
expressed by NC cells and are functionally active in these cells
(Movie 3). Moreover, addition of the ligand, PDGF-A, further
increased cell dispersion of wild-type NC cells (Fig. 4B,G;Movie 3)
or cells depleted of PDGFA (Fig. 4D), but it was unable to promote
dispersion in cells lacking PDGFRα (Fig. 4F,G; Movie 3), showing
again the specificity of the inhibition by PDGF-AMO and PDGFRα
MO. This suggests that PDGF-A/PDGFRα signalling regulates NC
dispersion at early pre-migratory stages.
One of the outcomes of EMT is that it promotes cell dispersion by
reducing cell-cell adhesion or increasing cell motility. As we
showed that depletion of PDGF-A/PDGFRα inhibits cell dispersion
without affecting cell motility, we decided to analyse cell-cell
adhesion. Members of the cadherin protein family are key cell-cell
adhesion molecules, and a switch from E- to N-cadherin is essential
for NC migration (Scarpa et al., 2015; Rogers et al., 2013).
Therefore, we investigated the impact of PDGFRα signalling on N-
and E-cadherin levels by western blot analysis of pre-migratory
cells. We observed a reduction of N-cadherin protein levels in
PDGFRα MO-injected NC cells (Fig. 4J,K), but no change in E-
cadherin (Fig. S1A,B). The specific decrease in N-cadherin, but not
E-cadherin, was further confirmed by immunofluorescence in
PDGFRα-depleted NC cells (Fig. 4H,I; Fig. S1C,D). Additionally,
we observed a similar decrease in N-cadherin staining in PDGF-A-
depleted cells (Fig. 4H,I, PDGF-A MO) and an opposite increase
after PDGF-A mRNA injection (Fig. 4H,I). These data suggest that
PDGF-A/PDGFRα signalling controls NC EMT and cell dispersion
at pre-migratory stages by regulating N-cadherin levels.
N-cadherin-dependent CIL is regulated by PDGF-A/PDGFRα
signalling
Our results show that inhibition of PDGF-A/PDGFRα reduces the
levels of N-cadherin protein at cell-cell contacts and, at the same
time, reduces cell dispersion. How can this decrease in N-cadherin
be related to a reduction in cell dispersion? It is known that
blocking N-cadherin leads to a loss of CIL behaviour in NC
(Theveneau et al., 2010). Hence, we hypothesized that decreased
dispersion in PDGFRα MO-injected explants could be caused by
N-cadherin-dependent loss of CIL. To address this, we used three
different assays to analyse CIL (Carmona-Fontaine et al., 2008b;
Moore et al., 2013; Scarpa et al., 2015). All of these assays were
Fig. 3. Only migratory NC cells migrate towards PDGF-A. (A) In vitro chemotaxis assay towards PDGF-A and SDF-1 protein-coated beads; representative
images of nuclear fluorescence-labelled NC clusters (cyan) with time-coded tracks from t=0 min to t=300 min are shown. (B) Chemotaxis index (CI) of migratory
NC with PDGF-A protein [control (n=50), PDGFRα MO (n=50)] and SDF-1 protein [control (n=47), PDGFRα MO (n=50)] beads. (C) In vitro chemotaxis assay
of pre-migratory (premig., stage 18) and migratory (mig., stage 22) NC clusters towards PDGF-A protein-coated beads; representative images of nuclear
fluorescence-labelled NC clusters (cyan) with time-coded tracks from t=0 min to t=300 min are shown. (D) CI of migratory NC with PDGF-A protein [pre-mig.
(n=131), mig. (n=115)] and SDF-1 protein [pre-mig. (n=100), mig. (n=100)] beads. Box plots show the median and 25th and 75th percentiles, whiskers are the
minimum and maximum values. ns, not significant; ****P<0.0001.
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performed using pre-migratory NC cells (stage 18). First, when
two cells undergoing CIL collide they remain briefly in contact
and then they move away from each other (Fig. 5A); however, if
CIL is impaired the two colliding cells remain in contact for longer
(Stramer and Mayor, 2016). We measured the time that pairs of
colliding cells remain together as an outcome of CIL. Our results
show that cells injected with PDGFRα MO remain in contact
significantly longer compared with control cells (Fig. 5B), with
some PDGFRα MO-injected cells never separating even after 10 h
of culture, indicating an impairment in the CIL response. Second,
when two cell explants that exhibit CIL are confronted they do not
overlap; therefore, an overlap between adjacent explants is an
indication of CIL impairment (Stramer and Mayor, 2016). Two
NC explants fluorescently labelled with distinct colours,
Fluorescein-Dextran and Rhodamine-Dextran, were cultured at a
short distance and the overlapping area between them was
analysed. Although control explants did not overlap, a clear
overlap was observed in explants in which the PDGFRα was
inhibited, indicating a clear reduction in CIL response (Fig. 5C,D).
Third, a direct consequence of CIL is the acquisition of cell
polarity, where cells extend a larger protrusion away from the
contact and become elongated, which has been linked to N-
cadherin-dependent cell adhesion (Scarpa et al., 2015; Theveneau
et al., 2010). To assess whether inhibition of PDGFRα changes
polarity, we measured the protrusion area away from the cell
contact and cell circularity. We found a significantly lower
protrusion area and higher circularity in PDGFRα MO-injected
cells compared with control cells (Fig. 5E-H), suggesting a change
in polarity. Overall, these data support the idea that PDGFRα is
controlling CIL via N-cadherin regulation.
PDGF-A/PDGFRα controls NC migration via the PI3K/AKT
signalling pathway
It is known that PDGFR can activate several signalling pathways,
such as the PI3K, MAPK, PKC, JAK-STAT and Src pathways
(Demoulin and Essaghir, 2014). Therefore, we were interested in
identifying the pathways involved in controlling CIL/N-cadherin in
pre-migratory NC cells. Studies in mouse and zebrafish during
Fig. 4. PDGF signalling affects NC
dispersion and N-cadherin levels.
(A-F) Nuclear fluorescence (nuclear RFP) of
NC explants cultured in vitro for the indicated
times with the indicated treatments. Scale bar:
100 µm. Bottom row shows analysis of cell
dispersion using Delaunay triangulation at
720 min. (G) NC dispersion analysis based on
average Delaunay triangulation area (μm2) of
control (n=43), PDGF-A protein (50 ng/ml,
n=31), PDGF-A MO (n=18), PDGF-A MO
+PDGF-A protein (n=13), PDGFRα MO
(n=30), PDGFRα MO+PDGF-A protein
(n=29) explant clusters from at least three
independent experiments. Box plots show the
median and 25th and 75th percentiles,
whiskers are the minimum and maximum
values. (H) Analysis of immunostaining against
N-cadherin; pixel intensity across cell-cell
contacts (0 μm), normalized to average cell
background level in control (n=43), PDGF-A
MO (n=50), PDGFRα MO (n=61), PDGF-A
mRNA (n=50) cells. Data are mean±s.e.m. AU,
arbitrary units. (I) Representative projections of
confocal images of immunostaining against
N-cadherin (green) and DAPI (blue) in control,
PDGF-A MO, PDGFRα MO and PDGF-A
mRNA-injected NC cells. Scale bar: 20 μm.
(J) Western blot against N-cadherin from NC
explants taken from control embryos or
embryos injected with PDGFRαMO. tAKT was
used as a loading control. (K) Normalized
levels of N-cadherin protein levels. Data are
mean±s.d. from three independent
experiments. ns, not significant;*P<0.05
**P<0.01; ***P<0.001.
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craniofacial NC migration suggested PI3K signalling as the main
downstream effector of PDGF signalling (He and Soriano, 2013;
Klinghoffer et al., 2001; Vasudevan et al., 2015). Therefore, we
asked whether the same pathways were activated in pre-migratory
NC cells during CIL.
To investigate the role of PI3K as a downstream component of
PDGFRα signalling, we expressed a biosensor (ph-AKT-GFP) of
PI3K activity, consisting of AKT pleckstrin homology (ph) domain
fused to GFP (Montero et al., 2003), in NC cells and analysed
PI3K/AKT activity by high time resolution microscopy. Activation
of PI3K results in the addition of a phosphate molecule
to phosphoinositides, generating phosphatidylinositol 3,4,5-
trisphosphate (PIP3). ph-AKT-GFP has a high and specific
affinity for PIP3 and therefore translocates to the plasma
membrane upon binding PIP3 (Hoch and Soriano, 2003). Thus, a
change in GFP intensity from the cytosolic to the membrane-bound
form can be used as a read-out of PI3K pathway activation. The
treatment of ph-AKT-GFP-expressing cells with PDGF-A protein
induced a clear increase in membrane GFP intensity compared with
control cells not treated with PDGF-A protein (Fig. 6A,B,D-F;
Movie 4). As a positive control, we co-injected the cells with PI3K-
CAAXmRNA, a dominant active form of PI3K, which resulted in a
strong membrane GFP response without the addition of PDGF-A
protein (Fig. 6C,D).
To further examine the role of PI3K/AKT signalling, we tested
for endogenous pathway activation by western blot analysis of
phosphorylated AKT (pAKT). Treatment with PDGF-A protein led
to an increase in AKT phosphorylation in NC cells (Fig. 6G,H),
suggesting an involvement of PI3K/AKT signalling downstream
of PDGF-A/PDGFRα. We observed no decrease in AKT
phosphorylation in PDGFRα MO-injected cells, probably because
the basal levels of AKT are already too low in control cells.
To investigate the role and specificity of PI3K/AKT signalling in
NC migration, we used pharmacological inhibitors (Fig. 7A) of
PDGFR (AG1296), PI3K (LY294002), AKT (MK2206) and MEK
(UO126). In vivo treatment with PDGFR, PI3K and AKT inhibitors
at the pre-migratory stage led to inhibition of NC migration
(Fig. 7B-G), supporting our earlier findings. No significant effect of
MEK inhibition on NC migration was detected (Fig. 7F,G). Next,
we investigated the effect of PI3K/AKT on pre-migratory NC cell
dispersion in vitro, which is considered as a CIL assay (Stramer and
Mayor, 2016). Treatment with PI3K (Fig. 7I,P, black bars) and AKT
(Fig. 7J,P, black bars) inhibitors led to inhibition of NC cell
dispersion compared with control NC cells (Fig. 7H,P, black bars).
Remarkably, treatment with the MEK inhibitor also resulted in a
reduction in NC cell dispersion (Fig. 7K,P, black bars), but had no
effect on NC cell migration in vivo (Fig. 7F,G). As some of these
inhibitors could also have nonspecific or off-target effects on other
pathways present in the NC, different to the one activated by PDGF-
A, we proceeded to use the inhibitors after treating the cell clusters
with PDGF-A protein. As previously shown, we observed that
treatment of NC cells with PDGF-A led to cell dispersion (Fig. 7L,P,
grey bars). However, this dispersion was dramatically impaired
when PDGF-A-treated cells were co-incubated with inhibitors of
PI3K (Fig. 7M,P, grey bars) and AKT (Fig. 7N,P, grey bars), but not
with the MEK inhibitor (Fig. 7O,P, grey bars). These results show
that PDGF-A promotes cell dispersion in a PI3K/AKT-dependent
manner, but independently of MEK, which is consistent with the
effect of the inhibitors of these pathways on NC migration in vivo.
The results using UO126, a MEK inhibitor, suggest some off-target
effects in vitro, but not in vivo, possibly because higher levels of the
inhibitor are reached in cells directly exposed to the culturemedium in
vitro but not in vivo. Immunoblotting for pAKT confirmed a decrease
after PDGFR inhibitor treatment (Fig. 7Q,T), similar to treatment
with the inhibitors of PI3K (Fig. 7R,U) and AKT (Fig. 7S,V). Taken
together, these data show that PDGF-A/PDGFRα controls NC
migration and dispersion via the PI3K/AKT signalling pathway.
N-cadherin-dependent CIL is regulated via PI3K/AKT
signalling downstream of PDGF-A/PDGFRα signalling
It is well-established that a cell cluster undergoing CIL will
disperse (Davis et al., 2015; Scarpa et al., 2015; Stramer and
Fig. 5. PDGF signalling controls CIL. (A,B) Single cell collision assay of the
time between first contact and separation. (A) Representative diagram of CIL.
(B) PDGFRα MO explants have impaired CIL, as indicated by the duration of
control-control (n=58) and PDGFRαMO-PDGFRαMOCIL events (n=63); data
are mean±s.d. from three independent experiments. (C) CIL assay, in which
the overlap between two differentially labeled explants is analyzed.
Thresholded images of explant invasion assay. Scale bar: 100 µm. (D) Overlap
percentage between two NC explants of control (n=52) and PDGFRα MO
(n=59) explants from three independent experiments. Scatter plots show
median and interquartile range. (E) Protrusions formed away from the cell
contact (labelled in white). Scale bar: 30 μm. (F) Protrusion area (μm2) of
control (n=51) and PDGFRα MO (n=41) cells. Scatter plots show median and
interquartile range. (G) Circularity index; representative examples of circularity
(indicated by yellow dashed line) of control and PDGFRα MO-injected NC
cells. (H) Circularity of control (n=79) and PDGFRα MO (n=73)-injected NC
cells. ns, not significant; *P<0.05; ***P<0.001.
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Mayor, 2016; Villar-Cerviño et al., 2013); conversely, the
inhibition of CIL causes impaired dispersion, as observed in
PDGF-A/PDGFRα MO-injected NC explants (Fig. 4C-G;
Movie 3). To assess whether this impaired dispersion is caused by
a lack of N-cadherin, we co-injected PDGFRαMOwith N-cadherin
mRNA. Interestingly, co-injection of PDGFRαMO and N-cadherin
mRNAwas sufficient to rescue the inhibition of dispersion induced
by PDGFRαMO (Fig. 8A-E; Movie 5). This observation indicates
that PDGF-A/PDGFRα signalling controls N-cadherin-dependent
CIL in NC cells.
Finally, to investigate whether the N-cadherin regulation that is
controlled by PDGF-A/PDGFRα (Fig. 4H-K) is also PDGFR-
PI3K/AKT dependent, we treated embryos with a PDGFR or PI3K
inhibitor, and analysed N-cadherin levels by western blotting at pre-
migratory stages. Both inhibitor treatments reduced N-cadherin
protein levels (Fig. 8F-I). In conclusion, these results demonstrate
that the tissue-intrinsic PDGF-A/PDGFRα-PI3K-AKT signalling
controls N-cadherin levels, which, in turn, are required for CIL
during NC EMT.
DISCUSSION
PDGF-A and PDGFα are functionally linked in the NC
Our results point to a double role of PDGF-A/PDGFRα in Xenopus
NCdevelopment. At early migratory stages (Fig. 8J), NC cells express
PDGFRα and its ligand PDGF-A, which activates the PI3K/AKT
pathway in a tissue-autonomous manner, leading to upregulation of
N-cadherin at the cell contact; this increase in N-cadherin is sufficient
to promote CIL and cell dispersion during EMT (Theveneau et al.,
2010; Scarpa et al., 2015). Once EMT has started and the NC cells are
migrating (Fig. 8K), the NC senses PDGF-A from the surrounding
tissues, which induces chemotaxis and promotes directional NC
migration as described previously in other animal models (Eberhart
et al., 2008; He and Soriano, 2013; Kawakami et al., 2011).
Consistent with our data, expression of PDGFRα has been
reported to be NC cell specific in mouse, zebrafish and Xenopus (Ho
et al., 1994; Liu et al., 2002b; Orr-Urtreger and Lonai, 1992).
However, in contrast to our finding that PDGF-A is expressed in
Xenopus cranial NC, the expression of PDGF-A in other animal
models has so far been attributed only to the NC cells surrounding
tissues (Ho et al., 1994; Liu et al., 2002a; Orr-Urtreger and Lonai,
1992). In support of PDGF-A being produced by the NC, we show
that depletion of PDGF-A in the NC by a morpholino inhibited NC
dispersion in vitro, in a condition in which the only possible source
of PDGF is the NC cells. So far, analysis of PDGF-A expression in
Xenopus migratory NC has only been performed using radioactive
in situ hybridization, in which expression can be confused with the
background signal (Ho et al., 1994). We confirmed our results on
the co-expression of PDGFRα and PDGF-A by using RT-PCR,
which is a much more sensitive technique than in situ hybridization.
Our data suggest that revisiting studies on PDGF-A expression
during early cephalic NC migration in other model organisms with
more recent and sensitive approaches would be worthwhile.
Various interactions between different ligands (PDGF-A, PDGF-
AB, PDGF-BB, PDGF-CC, PDGF-DD) and receptors (PDGFRα/
Rα, PDGFRβ/Rβ, PDGFRα/Rβ) have been described in vitro, but
only the depletion of PDGF-A and PDGF-C, upstream of PDGFRα
signalling, have been shown to be functionally important during
mouse embryonic development (Boström et al., 1996; Ding et al.,
2004; Soriano, 1997). We cannot rule out a potential role of PDGF-
C in Xenopus NC migration; nonetheless, a PDGF-C ligand has so
Fig. 6. AKT signalling downstream of
PDGFRα. (A-C) Confocal images of ph-AKT-
GFP (Akt-ph) mRNA-injected NC cells at t=0 s
and t=425 s. Scale bars: 20 μm. (A,E) Control, no
addition of PDGF-A protein. (B,F) PDGF-A
protein (50 ng/ml) added at 300 s. (C) PI3K-
CAAX mRNA-injected NC with no addition of
PDGF-A protein. (D) Analysis of ph-AKT-GFP
pixel intensity at the membrane normalized to
cytoplasmic ph-AKT-GFP levels over time.
PDGF-A addition control (PDGF-AA, n=12), no
PDGF-A addition control (no PDGF-AA, n=7),
PI3K-CAAX (n=10); data are mean±s.d. from
three independent experiments. (E,F) Time
course (10 min) of images at the cell membrane
showing membrane localization of
ph-AKT-GFP (E) with no PDGF-A addition and
(F) after PDGF-A addition. (G) Western blot
analysis of pAKT (Ser437) in control and PDGF-
A protein-treated (50 ng/ml for 60 min) NC
explant lysates. tAKT was used as a loading
control. (I) Band intensity normalized to loading
control. Data are mean±s.d. from three
independent experiments. AU, arbitrary units. ns,
not significant; *P<0.05.
2462
RESEARCH ARTICLE Development (2017) 144, 2456-2468 doi:10.1242/dev.147926
D
E
V
E
LO
P
M
E
N
T
Fig. 7. Small molecule inhibition of PI3K/AKT signalling. (A) Schematic of the PDGF-PI3K-AKT signalling axis. Signalling is activated upon PDGF ligand
(PDGF-AA) binding to the PDGF receptor (PDGFRα), inducing receptor dimerization and subsequent autophosphorylation. PI3K is activated, leading to the
phosphorylation of phosphoinositol (PI) residues in the plasma membrane, converting PIP2 to PIP3. Downstream effector kinase AKT binds [with its pleckstrin
homology (ph) domain] to PIP3 residues and is activated. (B-F) In situ hybridization for twist in stage 24 embryos treatedwith the indicated inhibitors from stage 14:
(B) DMSO control, (C) AG1296 (20 μM), (D) LY294002 (40 μM), (E) MK-2206 (100 μM), (F) UO126 (100 μM). Scale bar: 100 μm. Stars indicate the eye and
arrows indicate the neural crest stream. (G) NC migration normalized to the control average of each experiment in DMSO control (n=256), AG1296 (n=101),
LY294002 (n=40), MK-2206 (n=106) and UO126 (n=68) embryos. Data are mean±s.e.m. from three independent experiments. Scheme showing how the
migration was quantified is shown underneath the graph. (H-O) Dispersion analysis, using Delaunay triangulation, of NC cultured in vitro for 720 min with the
indicated treatments. (P) Analysis of NC dispersion, showing average Delaunay triangulation area normalized to the control of each experiment. Control (n=92),
LY294002 (5 μM, n=21), MK-2206 (5 μM, n=16), UO126 (25 μM, n=14), control and PDGF-A (n=55), LY294002 (5 μM) and PDGF-A (n=25), MK-2206 (5 μM) and
PDGF-A (n=35), UO126 (25 μM) and PDGF-A (n=19) explants; for all PDGF-A conditions, a PDGF-A concentration of 50 ng/ml was used. Data are mean±s.d.
(Q-S) Western blots against pAKT using lysates of whole embryos treated with small molecule inhibitors as indicated. tAKT was used as a loading control. (T-V)
Quantification of the western blots shown in Q-S, respectively; intensity of pAKT normalized to tAKT control. Data are mean±s.d. of three independent
experiments. AU, arbitrary units. ns, not significant; **P<0.01; ***P<0.001.
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far not been described for Xenopus laevis. Although PDGFRβ
expression has yet to be determined during Xenopus laevis
development, PDGFRα and PDGFRβ can form a heterodimer that
has been shown to be functionally active during NC migration
(Fantauzzo and Soriano, 2016; Klinghoffer et al., 2002; Richarte
et al., 2007), and future investigations should look at the potential
role of PDGFRβ during NC migration in the Xenopus.
We showed that loss of function of both PDGF-A and PDGFRα
inhibits NC cell migration in vivo using morpholinos against
PDGF-A and PDGFRα, a dominant-negative form of PDGFRα
and pharmacological inhibition of PDGFR phosphorylation
with AG1296. The morpholinos and dominant-negative form of
PDGFRα did not affect NC specification, excluding that the
inhibition of NCmigration is caused by a defect in NC specification.
In line with our data, mouse and zebrafish PDGFRα knockdown
studies have shown defects in cranial and cardiac NC-derived
tissues (Eberhart et al., 2008; Soriano, 1997; Tallquist and Soriano,
2003). In zebrafish and mouse cranial NC, PDGF-A has been
suggested as a chemokine during migration (Eberhart et al., 2008;
Kawakami et al., 2011). Here, we show that PDGF-A can work as a
chemoattractant, at least in vitro, for migratory, but not pre-
migratory, NC. Why pre-migratory NC cannot undergo chemotaxis
towards PDGF remains to be investigated.
PDGF signalling and CIL
Analysis of the cellular behaviour controlled by PDGFRα revealed
that NC dispersion is inhibited by PDGFRα depletion in
pre-migratory stages. Consistent with our observation, conditional
PDGFRα knockout mice have shown defects in explant outgrowth
(He and Soriano, 2013). NC cells are known to undergo EMT-like
dispersion in vitro (Kuriyama et al., 2014) due to a switch in the cell-
cell adhesion molecules E-cadherin to N-cadherin (Scarpa et al.,
Fig. 8. PDGFRα controls dispersion via PI3K/AKT in an N-cadherin-dependent manner. (A-D) Nuclear fluorescence (nuclear RFP) of NC explants cultured
in vitro for the indicated time with the indicated treatments. Scale bar: 100 µm. Bottom row shows analysis of cell dispersion using Delaunay triangulation at
720 min. (E) NC dispersion analysis based on average Delaunay triangulation area (μm2) of control (n=41), PDGFRαMO (n=19), N-cadherin-GFP mRNA (n=23)
and N-cadherin-GFP mRNA+PDGFRα MO (n=23) explants. Box plots show median and 25th and 75th percentiles, whiskers are the minimum and maximum
values. (F,G) Western blot against N-cadherin using lysates of NC cells treated with DMSO, AG1296 (20 μM, n=3 blots) or LY294002 (40 μM, n=3 blots). GADPH
was used as a loading control. (H,I) Band intensity of N-cadherin normalized to the loading control. Data are mean±s.d. of three independent experiments.
AU, arbitrary units. ns, not significant; **P<0.01; ***P<0.001. (J,K) Schematic of the effects of PDGFRα/PDGF-A on (J) early and (K)mid NCmigration. See text for
further details.
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2015). In line with these data, we demonstrate that PDGFRα
signalling controls NC cell-cell adhesion by regulating N-cadherin
levels. Importantly, overexpression of N-cadherin mRNA resulted
in rescue of inhibition of dispersion, strongly suggesting that
PDGFRα signalling works upstream of N-cadherin levels.
N-cadherin has been shown to be required for CIL, and a cell-cell
adhesion complex formed by N-cadherin, p120, α-catenin and β-
catenin is transiently assembled upon cell-cell interactions in cranial
NC (Kuriyama et al., 2014; Theveneau et al., 2010). More recently,
the acquisition of CIL behaviour has been linked to EMT and a
switch to N-cadherin in Xenopus cranial NC cell migration (Scarpa
et al., 2015). In context with these findings, we demonstrate that
PDGFRα MO-injected NC cells were not able to undergo efficient
CIL (Fig. 5), supporting the hypothesis that PDGFRα is regulating
CIL. N-cadherin expression promotes polarization of RAC1 activity
towards the leading edge during CIL, and N-cadherin-depleted cells
display a reduction in protrusion size (Theveneau et al., 2010). As
expected, owing to the reduction in N-cadherin, PDGFRα MO-
injected NC cell explants displayed a decrease in protrusion area,
indicating a loss of polarity. This suggests that PDGFRα signalling
controls EMT in a CIL-dependent manner by regulating N-cadherin
levels. NC cell EMT and migration does have many similar
characteristic with malignant cancer invasion. In line with this and
our data, PDGF signalling has been implicated in EMT during
cancer invasion (Eckert et al., 2011; Jechlinger et al., 2006; Thiery
and Sleeman, 2006). Furthermore, mouse studies reported that
conditional pdgfra knockout in NC, using a Wnt1-Cre1 driver,
resulted in platogenesis defects, linked to delayed migration of NC
in the frontonasal prominence (He and Soriano, 2013; Tallquist and
Soriano, 2003). This delayed migration in mouse could be
consistent with the observed phenotype of CIL reduction in
PDGFRα-depleted NC.
Signalling downstream of PDGF in NC
Using a biosensor and pharmacological inhibition, we were able to
link PDGFRα signalling to the PI3K/AKT downstream pathway.
PI3K signalling downstream of PDGFRα appears to be a conserved
mechanism in development. In mouse, PDGFRα depletion of PI3K
activation results in abnormalities in craniofacial development
(Klinghoffer et al., 2002). Also, an increase in PI3K signalling
is able to rescue craniofacial development in zebrafish from
a PDGFRα knockdown background (McCarthy et al., 2013).
Although these studies focus on the later, frontonasal migration of
cranial NC cells, PI3K/AKT cytoplasmic signalling appears to be
conserved for NC development.
Spatial PI3K activation in the leading edge of migrating cells has
been shown to be a crucial intracellular guidance cue in cell culture
assays andDictyostelium (Cain and Ridley, 2009; Merlot and Firtel,
2003; Yamaguchi et al., 2015). Contrary to this, we did not detect
high levels of ph-AKT-GFP localization without PDGF-A protein
addition at the free edge. This is most likely due to low levels
of PDGF-A protein, and a more sensitive sensor might reveal
intracellular spatial differences in PI3K localization.
We were able to control the CIL-dependent dispersion process in
NC cells by modulating PDGF-A/PDGFRα signalling. Depletion
of PDGF-A/PDGFRα signalling inhibited dispersion. Most
importantly, the inhibition of dispersion by PDGFRα depletion
could be rescued by co-injection with N-cadherin, thus proving
N-cadherin as the downstream target of the PDGFRα cellular
response. Further analysis by immunoblotting showed that
pharmacological inhibition of the PDGFR/PI3K/AKT axis does
indeed lead to a downregulation of N-cadherin. This demonstrates
N-cadherin as a regulator of CIL controlled by PI3K/AKT
signalling. A remaining question for further studies will be the
link between AKT and N-cadherin regulation.
The requirement of N-cadherin for proper NC migration has been
shown in chick, mouse, Xenopus and zebrafish embryos (Nakagawa
and Takeichi, 1998; Xu et al., 2001; Luo et al., 2006; Shoval et al.,
2007; Theveneau et al., 2010; Rogers et al., 2013; Scarpa et al.,
2015; Broders-Bondon et al., 2016). Here, we show that the
regulation of N-cadherin at the pre-migratory NC stages is PDGF-A/
PDGFRα dependent and that loss of N-cadherin by depletion of
PDGFRα signalling leads to an inhibition of NCmigration. Our data
suggest that, at these early stages, inhibition of NC migration by
PDGFRα depletion is due to N-cadherin-dependent impairment of
CIL. Furthermore, they suggest that the PI3K/AKT pathway is the
downstream effector of PDGF signalling during NC EMT.
MATERIALS AND METHODS
Embryos, microinjections and micromanipulation
Animals were used according to instructions from the Home Office of the
UnitedKingdom,where animal licences are required.Xenopus laevis embryos
were obtained and staged as described previously (Nieuwkoop and Faber,
1967), and the embryoswere injected at the eight- to 16-cell stage aspreviously
described (Carmona-Fontaine et al., 2008b). Explants were dissected at stage
17 for in vitro experiments and plated on a fibronectin-coated dish using 10 or
50 μg/ml fibronectin (Sigma-Aldrich) for plastic or glass dishes, respectively,
in DFAmedium as described previously (Theveneau et al., 2010). For in vivo
experiments, Fluorescein-Dextran (3 μg, D1821, Invitrogen) or Rhodamine-
Dextran (3 μg, D1824, Invitrogen) were used as tracers, and embryos were
fixed at stage 24 to perform twist in situ hybridization. Embryos were treated
fromstage14/15 to stage24with smallmolecule inhibitors, and equal amounts
of DMSO were used as controls.
Single-cell migration, chemotaxis, cell dispersion and CIL
Cell dissociation was performed by incubating in Ca2+Mg2+-free DFA for 3-
5 min before transferring to normal DFA medium. Cells were tracked using
the ImageJ Manual Tracking plugin (http://rsb.info.nih.gov/ij). Track speed
and persistence were determined using the ImageJ Chemotaxis Tool plugin.
Chemotaxis assay was performed as described previously (Theveneau et al.,
2010). Heparin-acrylic beads (H5263, Sigma-Aldrich) were incubated
overnight at 4°C in a 1 mg/ml SDF1 or 1 mg/ml PDGF-AA (AF-100-13A,
PeproTech) solution in PBS. To measure dispersion, NC cells from embryos
injected with H2B-mCherry (Carmona-Fontaine et al., 2008b) were imaged
for 12 h, and nuclei triangulation was analysed using the ImageJ Delaunay
Triangulation plugin (Carmona-Fontaine et al., 2011). For small molecule
inhibitor treatment, inhibitors were incubated 1 h before addition of PDGF-
A protein (50 ng/ml, PeproTech). To study CIL, an explant confrontation
assay was performed as described by Carmona-Fontaine et al. (2008a). For
the single-cell confrontation assay, single-cell CIL time was measured from
the first frame of contact (t=0) until the last frame of contact (t=end).
Protrusion area was analysed as previously described (Law et al., 2013).
RNAs, morpholinos and inhibitors
PDGF-A MO (8 ng, 5′-AGAATCCAAGCCCAGATCCTCATTG-3′)
(Nagel et al., 2004) and the newly designed PDGFRα MO (16 ng, 5′-
TGCCCTCATGGCAGGCATCATGGAC-3′) were obtained from Gene
Tools. Mouse mRNA mismatches are underlined. Plasmids were linearized
and mRNA transcribed using mMessenger mMachine Transcription Kits
(Thermo Fisher Scientific). The mRNA constructs injected were membrane
GFP (300 pg), nuclear RFP (300 pg, H2B-RFP), PDGFRαw37 (300 pg)
(Ataliotis et al., 1995), ph-AKT-GFP (500 pg) (Montero et al., 2003), PI3K-
p110CAAX (300 pg) (Montero et al., 2003), mouse PDGF-A (200 pg)
(Fruttiger et al., 1999), mouse PDGFRα (300 pg, IMAGE ID 5704645) and
N-cadherin (300 pg) (Scarpa et al., 2015). For mouse PDGF-A mRNA
transcription, mouse PDGF-A pGEM-1 (Fruttiger et al., 1999) was
linearized with PvuII (Promega) and transcribed with SP6 polymerase
(Promega). For mouse transcription PDGFRα I.M.A.G.E. Consortium
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Vector was linearized with PacI (Promega) and transcribed using T7
polymerase (Promega). Pharmacological inhibitors were all solubilized in
DMSO (Sigma-Aldrich) and appropriate DMSO controls were used for all
experiments. AG1296 (in vivo 20 μM, 658551, Merck Millipore),
LY294002 (in vivo 40 μM, in vitro 5 μM, 9901, Cell Signaling
Technology), MK-2206 (in vivo 100 μM, in vitro 5 μM, 1684, Axon
Medchem), UO126 (in vivo 100 μM, in vitro 25 μM, 9903, Cell Signaling
Technology).
Semi-quantitative RT-PCR
RNAs were extracted from NC or ventral non-NC tissue using an RNeasy
Mini Kit (Qiagen). cDNA were reverse transcribed using an ImProm-II
Reverse Transcription System (Promega). PCR cycles were analysed in pilot
experiments. For a primer list and annealing temperatures see Table S1.
Western blotting, in situ hybridization and immunostaining
For immunoblotting, NC cells were lysed (25 cells/lane) in a lysis buffer
containing 100 mM Tris-HCl (pH 8.0), 1% Triton X-100, 0.01% SDS,
cOmplete Mini Protease Inhibitor Cocktail (Roche) and PhosSTOP
Phosphatase Inhibitor Cocktail Tablets (Roche). Protein fractions were
isolated by centrifugation (19,500 g, 4°C) in two rounds for whole embryo
lysates. NC lysates were applied to SDS gels without the purification step.
Protein lysates were analysed by SDS-PAGE using 4-12% NuPAGE Bis-
Tris gels (Invitrogen), and subsequently transferred onto Invitrolon
polyvinylidene difluoride membranes (Invitrogen). Membranes were
blocked with 5% nonfat dry milk and 0.1% Tween-20 in PBS for 1 h at
room temperature, before being probed with the primary antibody by
overnight incubation at 4°C, followed by incubation for 1 h at room
temperature with a horseradish peroxidase-linked secondary antibody
(sc-2030; 1:3000; Santa Cruz Biotechnology) and detection using an ECL
reagent (Luminata Forte Western HRP Substrate, Millipore). Band intensity
was measured by scanning films and analysing by densitometry using
ImageJ. In situ hybridization was performed as described (Harland, 1991).
NC was labelled with digoxigenin-labelled RNA probes against
slug (Mayor et al., 1995) or twist (Hopwood et al., 1989) in Xenopus.
Immunostaining was performed according to standard procedures
(Carmona-Fontaine et al., 2008b). The following antibodies were used:
PDGFRα (1:2000, 3164, Cell Signaling Technology), pAKT Ser437
(1:2000, 9271, Cell Signaling Technology), total (pan) AKT (1:2000, 4691,
Cell Signaling Technology), GAPDH-HRP (1:2000, sc20357, Santa Cruz
Biotechnology), N-cadherin (western blotting 380 ng/ml, immunostaining
6 μg/ml, MNCD-2, DHSB) and E-cadherin (western blotting 60 ng/ml,
immunostaining 120 μg/ml, 5D3, DHSB). If required, DAPI was applied
with the secondary antibody (20 μg/ml, D9542, Sigma-Aldrich).
Statistical analysis
Significant differences between two data sets were determined using
contingency tables as previously described (Carmona-Fontaine et al.,
2008b) [the null hypothesis was rejected if T>3.841 (α=0.05), T>6.635
(α=0.01) or T>10.83 (α=0.001)]. Data sets (western blot data) were analysed
as follows: normality was evaluated by the Kolmogorov–Smirnov test and
d’Agostino–Pearson test; data sets were treated as normal distributed if found
so by the two tests. Normal distributed data were compared using Student’s
t-test (two-tailed, unequal variances) or one-way ANOVAwith a Dunnett’s
multiple comparisons post-test. Data sets that were found not to follow
a normal distribution were compared using Mann–Whitney’s test or a
nonparametric ANOVA in Prism 5 (GraphPad). Normalized western
blot data were analysed by one-way ANOVA followed by Student
Newman–Keuls test for multiple comparison differences. All analyses
were performed in Prism 5 (GraphPad).
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